Porsbjerg C, Brannan J D, Anderson S D, Backer V
Respiratory Research Unit, Department of Respiratory Medicine, Bispebjerg Hospital, University Hospital of Copenhagen, Copenhagen NV, Denmark.
Clin Exp Allergy. 2008 Jan;38(1):43-50. doi: 10.1111/j.1365-2222.2007.02878.x. Epub 2007 Nov 19.
Airway hyperresponsiveness (AHR) to stimuli that cause bronchial smooth muscle (BSM) contraction indirectly through the release of endogenous mediators is thought to reflect airway inflammation more closely compared with AHR measured by stimuli that act directly on BSM.
Fifty-three adult non-smoking asthmatics (28 females, 18-56 years) who were not taking inhaled steroids were challenged with mannitol (up to 635 mg) and methacholine (up to 8 mumol). Induced sputum eosinophils, exhaled nitric oxide (eNO), peak flow variation and clinical severity of asthma according to the Global Initiative for Asthma guidelines were measured in addition to the health-related quality-of-life score using the Juniper asthma quality-of-life questionnaire.
Both AHR to mannitol as well as to methacholine was associated with elevated markers of airway inflammation: in 83% of asthma patients with AHR to mannitol, and in 88% of asthma patients with AHR to methacholine, the eNO level was >20 p.p.b. Sputum% eosinophils >1% was measured in 70% of asthma patients with AHR to mannitol and in 77% of asthma patients with AHR to methacholine. In asthma patients without AHR, 15% had an eNO level >20 p.p.b., but none had sputum% eosinophils >1%. AHR to mannitol was more closely associated with the percentage of sputum eosinophils (PD(15) to mannitol vs. sputum% eosinophils: r: -0.52, P<0.05), compared with AHR to methacholine (PD(20) to methacholine vs. sputum% eosinophils: r: -0.28, NS). Furthermore, there was a stronger correlation between AHR to mannitol and the level of eNO [PD(15) to mannitol vs. eNO (p.p.b.): r: -0.63, P<0.001], compared with AHR to methacholine [PD(20) to methacholine vs. eNO (p.p.b.): r: -0.43, P<0.05].
In asthma patients not being treated with steroids, AHR to mannitol and to methacholine indicated the presence of airway inflammation. AHR to mannitol reflected the degree of airway inflammation more closely when compared with methacholine.
与通过直接作用于支气管平滑肌(BSM)的刺激所测得的气道高反应性(AHR)相比,对通过内源性介质释放间接引起支气管平滑肌收缩的刺激的AHR,被认为能更密切地反映气道炎症。
53名未使用吸入性类固醇的成年非吸烟哮喘患者(28名女性,年龄18 - 56岁)接受了甘露醇(最高635毫克)和乙酰甲胆碱(最高8微摩尔)的激发试验。除了使用Juniper哮喘生活质量问卷评估健康相关生活质量得分外,还测量了诱导痰嗜酸性粒细胞、呼出一氧化氮(eNO)、峰流速变化以及根据全球哮喘防治创议指南评估的哮喘临床严重程度。
对甘露醇和乙酰甲胆碱的AHR均与气道炎症标志物升高相关:在对甘露醇有AHR的哮喘患者中,83%的患者eNO水平>20 ppb;在对乙酰甲胆碱有AHR的哮喘患者中,88%的患者eNO水平>20 ppb。在对甘露醇有AHR的哮喘患者中,70%的患者痰液嗜酸性粒细胞百分比>1%;在对乙酰甲胆碱有AHR的哮喘患者中,77%的患者痰液嗜酸性粒细胞百分比>1%。在无AHR的哮喘患者中,15%的患者eNO水平>20 ppb,但无一例患者痰液嗜酸性粒细胞百分比>1%。与对乙酰甲胆碱的AHR相比,对甘露醇的AHR与痰液嗜酸性粒细胞百分比的相关性更强(甘露醇PD(15)与痰液嗜酸性粒细胞百分比:r: -0.52,P<0.05)(乙酰甲胆碱PD(20)与痰液嗜酸性粒细胞百分比:r: -0.28,无统计学意义)。此外,与对乙酰甲胆碱的AHR相比,对甘露醇的AHR与eNO水平的相关性更强[甘露醇PD(15)与eNO(ppb):r: -0.63,P<0.001](乙酰甲胆碱PD(20)与eNO(ppb):r: -0.43,P<0.05)。
在未接受类固醇治疗的哮喘患者中,对甘露醇和乙酰甲胆碱的AHR表明存在气道炎症。与乙酰甲胆碱相比,对甘露醇的AHR能更密切地反映气道炎症程度。